• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外囊泡与癌症多药耐药性:不良的细胞间信使?

Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?

作者信息

Bucci-Muñoz María, Gola Aldana Magalí, Rigalli Juan Pablo, Ceballos María Paula, Ruiz María Laura

机构信息

Facultad de Ciencias Bioquímicas y Farmacéuticas (UNR), Instituto de Fisiología Experimental (CONICET), Rosario 2000, Argentina.

Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.

出版信息

Life (Basel). 2023 Jul 27;13(8):1633. doi: 10.3390/life13081633.

DOI:10.3390/life13081633
PMID:37629489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10455762/
Abstract

Cancer multidrug resistance (MDR) is one of the main mechanisms contributing to therapy failure and mortality. Overexpression of drug transporters of the ABC family (ATP-binding cassette) is a major cause of MDR. Extracellular vesicles (EVs) are nanoparticles released by most cells of the organism involved in cell-cell communication. Their cargo mainly comprises, proteins, nucleic acids, and lipids, which are transferred from a donor cell to a target cell and lead to phenotypical changes. In this article, we review the scientific evidence addressing the regulation of ABC transporters by EV-mediated cell-cell communication. MDR transfer from drug-resistant to drug-sensitive cells has been identified in several tumor entities. This was attributed, in some cases, to the direct shuttle of transporter molecules or its coding mRNA between cells. Also, EV-mediated transport of regulatory proteins (e.g., transcription factors) and noncoding RNAs have been indicated to induce MDR. Conversely, the transfer of a drug-sensitive phenotype via EVs has also been reported. Additionally, interactions between non-tumor cells and the tumor cells with an impact on MDR are presented. Finally, we highlight uninvestigated aspects and possible approaches to exploiting this knowledge toward the identification of druggable processes and molecules and, ultimately, the development of novel therapeutic strategies.

摘要

癌症多药耐药性(MDR)是导致治疗失败和死亡的主要机制之一。ABC家族(ATP结合盒)药物转运蛋白的过表达是MDR的主要原因。细胞外囊泡(EVs)是机体大多数细胞释放的参与细胞间通讯的纳米颗粒。其货物主要包括蛋白质、核酸和脂质,它们从供体细胞转移到靶细胞并导致表型变化。在本文中,我们综述了关于EV介导的细胞间通讯对ABC转运蛋白调控的科学证据。在多个肿瘤实体中已发现多药耐药性从耐药细胞转移到敏感细胞。在某些情况下,这归因于转运蛋白分子或其编码mRNA在细胞间的直接穿梭。此外,有研究表明EV介导的调节蛋白(如转录因子)和非编码RNA的转运可诱导多药耐药性。相反,也有报道称通过EVs可转移药物敏感表型。此外,还介绍了非肿瘤细胞与肿瘤细胞之间对多药耐药性有影响的相互作用。最后,我们强调了尚未研究的方面以及利用这些知识来识别可成药过程和分子并最终开发新治疗策略的可能方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1645/10455762/bcfe8e7e34ae/life-13-01633-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1645/10455762/7a67cd6b6710/life-13-01633-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1645/10455762/bcfe8e7e34ae/life-13-01633-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1645/10455762/7a67cd6b6710/life-13-01633-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1645/10455762/bcfe8e7e34ae/life-13-01633-g002.jpg

相似文献

1
Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?细胞外囊泡与癌症多药耐药性:不良的细胞间信使?
Life (Basel). 2023 Jul 27;13(8):1633. doi: 10.3390/life13081633.
2
Extracellular Vesicles in Chemoresistance.细胞外囊泡在化疗耐药中的作用
Subcell Biochem. 2021;97:211-245. doi: 10.1007/978-3-030-67171-6_9.
3
Intercellular transfer of multidrug resistance mediated by extracellular vesicles.细胞外囊泡介导的多药耐药性的细胞间转移。
Cancer Drug Resist. 2024 Sep 21;7:36. doi: 10.20517/cdr.2024.84. eCollection 2024.
4
The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.非编码 RNA 在 ABC 转运蛋白调控中的作用及其在癌症多药耐药中的临床意义。
Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):291-306. doi: 10.1080/17425255.2021.1887139. Epub 2021 Feb 22.
5
Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics.通过光破坏富含 ABCG2 的细胞外囊泡来克服多药耐药性,这些囊泡隔离了光敏感的化疗药物。
PLoS One. 2012;7(4):e35487. doi: 10.1371/journal.pone.0035487. Epub 2012 Apr 18.
6
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.提高传统抗癌药物作为对抗多药耐药肿瘤的新工具。
Drug Resist Updat. 2020 May;50:100682. doi: 10.1016/j.drup.2020.100682. Epub 2020 Feb 7.
7
β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.β-胡萝卜素通过选择性调节人 P-糖蛋白功能逆转多药耐药癌细胞。
Phytomedicine. 2016 Mar 15;23(3):316-23. doi: 10.1016/j.phymed.2016.01.008. Epub 2016 Feb 6.
8
Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles.鉴定与癌症多药耐药表型相关的代谢改变及其通过细胞外囊泡介导的细胞间转移。
Sci Rep. 2017 Mar 17;7:44541. doi: 10.1038/srep44541.
9
Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.通关藤及其主要活性成分多氧孕甾烷逆转多药耐药性
J Ethnopharmacol. 2017 May 5;203:110-119. doi: 10.1016/j.jep.2017.03.051. Epub 2017 Mar 28.
10
Deep Sequencing Analysis Reveals Distinctive Non-Coding RNAs When Comparing Tumor Multidrug-Resistant Cells and Extracellular Vesicles with Drug-Sensitive Counterparts.深度测序分析揭示,在比较肿瘤多药耐药细胞及细胞外囊泡与其药物敏感对应物时存在独特的非编码RNA。
Cancers (Basel). 2020 Jan 14;12(1):200. doi: 10.3390/cancers12010200.

引用本文的文献

1
A two-decade bibliometric analysis of drug resistance in oral cancer research: patterns, trends, and future directions.口腔癌研究中耐药性的二十年文献计量分析:模式、趋势及未来方向
Discov Oncol. 2025 Apr 1;16(1):441. doi: 10.1007/s12672-025-02225-8.
2
Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance.细胞外囊泡作为对抗癌症耐药性的介质和潜在靶点。
Molecules. 2025 Jan 23;30(3):498. doi: 10.3390/molecules30030498.
3
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds.

本文引用的文献

1
Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges.克服癌症多药耐药性(MDR):原因、机制、纳米治疗解决方案及挑战
Biomed Pharmacother. 2023 Jun;162:114643. doi: 10.1016/j.biopha.2023.114643. Epub 2023 Apr 7.
2
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers.癌症多药耐药相关分子机制的研究进展
Acta Pharm Sin B. 2023 Mar;13(3):982-997. doi: 10.1016/j.apsb.2022.10.002. Epub 2022 Oct 7.
3
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines.
囊泡转运介导的多药耐药性作为天然化合物可能的治疗靶点
Pharmaceuticals (Basel). 2024 Oct 11;17(10):1358. doi: 10.3390/ph17101358.
4
Chemoresistance and the tumor microenvironment: the critical role of cell-cell communication.化疗耐药性与肿瘤微环境:细胞间通讯的关键作用。
Cell Commun Signal. 2024 Oct 10;22(1):486. doi: 10.1186/s12964-024-01857-7.
5
E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells.E2F1介导同居的耐药和敏感卵巢癌细胞之间的竞争、增殖以及对顺铂的反应。
Front Oncol. 2024 Jan 26;14:1304691. doi: 10.3389/fonc.2024.1304691. eCollection 2024.
紫杉醇、雷莫西尤单抗和艾拉司群的多重组合可逆转胃癌细胞系中紫杉醇介导的耐药性。
Front Oncol. 2023 Feb 16;13:1129832. doi: 10.3389/fonc.2023.1129832. eCollection 2023.
4
Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.外泌体 microRNAs 的转移赋予骨肉瘤细胞多柔比星耐药性。
Mol Med Rep. 2023 Apr;27(4). doi: 10.3892/mmr.2023.12973. Epub 2023 Mar 3.
5
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy.肿瘤内微生物群:在癌症发生、发展和治疗效果中的作用。
Signal Transduct Target Ther. 2023 Jan 16;8(1):35. doi: 10.1038/s41392-022-01304-4.
6
Exosomal circ_0091741 promotes gastric cancer cell autophagy and chemoresistance via the miR-330-3p/TRIM14/Dvl2/Wnt/β-catenin axis.外泌体circ_0091741通过miR-330-3p/TRIM14/Dvl2/Wnt/β-连环蛋白轴促进胃癌细胞自噬和化疗耐药。
Hum Cell. 2023 Jan;36(1):258-275. doi: 10.1007/s13577-022-00790-6. Epub 2022 Nov 3.
7
Molecular mechanism of CD163 tumor-associated macrophage (TAM)-derived exosome-induced cisplatin resistance in ovarian cancer ascites.CD163肿瘤相关巨噬细胞(TAM)衍生的外泌体诱导卵巢癌腹水顺铂耐药的分子机制
Ann Transl Med. 2022 Sep;10(18):1014. doi: 10.21037/atm-22-4267.
8
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance.肿瘤对免疫检查点阻断的耐药机制及克服耐药的联合策略。
Front Immunol. 2022 Sep 15;13:915094. doi: 10.3389/fimmu.2022.915094. eCollection 2022.
9
Nanomedicines for Overcoming Cancer Drug Resistance.用于克服癌症耐药性的纳米药物。
Pharmaceutics. 2022 Aug 1;14(8):1606. doi: 10.3390/pharmaceutics14081606.
10
Endothelial extracellular vesicles promote tumour growth by tumour-associated macrophage reprogramming.内皮细胞外囊泡通过肿瘤相关巨噬细胞重编程促进肿瘤生长。
J Extracell Vesicles. 2022 Jun;11(6):e12228. doi: 10.1002/jev2.12228.